{
    "clinical_study": {
        "@rank": "104398", 
        "arm_group": [
            {
                "arm_group_label": "Placebo +/- 30% Nitrous oxide", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Sevoflurane 0.2% +/- 30% Nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "Sevoflurane 0.4% +/- 30% Nitrous oxide", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the effects of combined sevoflurane and nitrous\n      oxide inhalation on mood, psychomotor performance, and the pain response in humans."
        }, 
        "brief_title": "Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14", 
        "completion_date": {
            "#text": "February 1999", 
            "@type": "Actual"
        }, 
        "condition": [
            "Opioid-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Opioid-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000262", 
            "org_study_id": "NIDA-08391-14", 
            "secondary_id": [
                "R01DA008391", 
                "R01-08391-14"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Placebo +/- 30% Nitrous oxide", 
                    "Sevoflurane 0.2% +/- 30% Nitrous oxide", 
                    "Sevoflurane 0.4% +/- 30% Nitrous oxide"
                ], 
                "intervention_name": "30% Nitrous oxide", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sevoflurane 0.4% +/- 30% Nitrous oxide", 
                "intervention_name": "0.4% Sevoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sevoflurane 0.2% +/- 30% Nitrous oxide", 
                "intervention_name": "0.2% sevoflurane", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo +/- 30% Nitrous oxide", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nitrous Oxide", 
                "Sevoflurane"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "July 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60637"
                }, 
                "name": "University of Chicago, Anesthesia & Critical Care"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effects of Combined Sevoflurane and Nitrous Oxide Inhalation", 
        "overall_official": {
            "affiliation": "University of Chicago", 
            "last_name": "James Zacny, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 1999", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Inhalation was for 68 min divided into 4 blocks with nitrous oxide added during either block 2 or block 4", 
                "measure": "Pain intensity, pain bothersomeness", 
                "safety_issue": "No", 
                "time_frame": "During inhalation"
            }, 
            {
                "description": "Inhalation was for 68 min divided into 4 blocks with nitrous oxide added during either block 2 or block 4", 
                "measure": "Mood", 
                "safety_issue": "No", 
                "time_frame": "During inhalation"
            }, 
            {
                "description": "Inhalation was for 68 min divided into 4 blocks with nitrous oxide added during either block 2 or block 4", 
                "measure": "Psychomotor performance", 
                "safety_issue": "No", 
                "time_frame": "During inhalation"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000262"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Chicago", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 1996", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }, 
    "geocoordinates": {
        "University of Chicago, Anesthesia & Critical Care": "41.878 -87.63"
    }
}